Effects of fluoxetine on wild and mutant neuronal α7 nicotinic receptors

Molecular Psychiatry

Volumn 3, Issue 4, 1998, Pages 350-355

  Maggi, L ^a   Palma, E ^a   Miledi, R ^b   Eusebi, F ^a,c  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Fluoxetine; Neuronal nicotinic receptors; Xenopus oocytes; 7 mutant receptor

Indexed keywords

FLUOXETINE; NICOTINIC RECEPTOR; SEROTONIN;

ALCOHOLISM; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; DEPRESSION; DRUG DETOXIFICATION; DRUG EFFECT; EMBRYO; NERVE ENDING; NONHUMAN; OBESITY; OOCYTE; PRIORITY JOURNAL; XENOPUS;

EID: 0031819995     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000392     Document Type: Article

References (26)

1. 7) is developmentally regulated and forms a homo-oligomeric channel blocked by α-BuTX. Neuron 1990; 5: 847-856.
2. Ragozzino D, Fucile S, Giovannelli A, Grassi F, Mileo A, Ballivet M et al. Functional properties of neuronal nicotinic acetylcholine receptor-channels expressed in transfected human cells. Eur J Neurosci 1997; 9: 480-488.
3. Bertrand D, Dellivers-Thiery A, Revah F, Galzi JL, Hussy N, Mulle C et al. Unconventional pharmacology of a neuronal nicotinic receptor mutated in the channel domain. Proc Natl Acad Sci USA 1992; 89: 1261-1265.
4. 7 nicotinic receptor converts 5-hydroxytryptamine from antagonist to agonist. Proc Natl Acad Sci USA 1996; 93: 11231-11235.
5. Revah F, Bertrand D, Galzi J-L, Devillers-Thiery A, Mulle C, Hussy N et al. Mutations in the channel domain alter desensitization of a neuronal nicotinic receptor. Nature 1991; 353: 846-849.
6. Wong DT, Bymaster F, Engleman EA. Prozac (Fluoxetine, Lilly 110140) the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication. Life Sci 1995; 57: 412-441.
7. Garcia-Colunga J, Award JN, Miledi R. Blockage of muscle and neuronal nicotinic acetylcholine receptors by Fluoxetine (Prozac). Proc Natl Acad Sci USA 1997; 94: 2041-2044.
8. 8 subunits of nicotinic receptors exhibit similar channel but contrasting binding site properties. Mol Pharmacol 1994; 45: 212-220.
9. 7 receptor expressed in Xenopus oocytes presents five putative binding sites for methyllycaconitine. J Physiol (Lond) 1996; 491.1: 151-161.
10. Schoepfer R, Conroy WG, Whiting P, Gore M, Lindstrom J. Brain α-bungarotoxin binding protein cDNAs and MAbs reveal subtypes of this branch of the ligand-gated ion channel gene superfamily. Neuron 1990; 5: 35-48.
11. 7 nicotinic receptor mutants. Neuro Report 1997; 8: 3591-3596.
12. 7 mutant receptors show different gating kinetics when activated by AcCho or by the non-competitive agonist 5-hydroxytryptamine. Proc Natl Acad Sci USA 1997; 94: 9915-9919.
13. Beck SG, Birnstiel S, Choi KC, Pouliot WA. Fluoxetine selectively alters 5-hydroxytryptamine 1A and gamma-aminobutyric acid B receptor-mediated hyperpolarization in area CA1, but not area CA3, hippocampal pyramidal cells. J Pharmacol Exp Ther 1997; 281: 115-122.
14. Collu M, Poggiu AS, Devoto P, Serra G. Behavioural sensitization of mesolimbic dopamine D2 receptors in chronic Fluoxetine-treated rats. Eur J Pharmacol 1997; 322: 123-127.
15. Ni YG, Miledi R. Blockage of 5HT2C serotonin receptors by Fluoxetine (Prozac). Proc Natl Acad Sci USA 1997; 94: 2036-2040.
16. McGehee DS, Role LW. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu Rev Physiol 1995; 57: 521-546.
17. Sargent PB. The diversity of neuronal nicotinic acetylcholine receptors. Annu Rev Neurosci 1993; 16: 403-443.
18. Wonnacot S. Presynaptic nicotinic ACh receptors. TINS 1997; 20: 92-98.
19. Freedman R, Coon H, Myles-Worsley M, Orr-Urtreger A, Olincy A, Davis A et al. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci USA 1997; 94: 587-592.
20. Gotti C, Fornasari D, Celmenti F. Human neuronal nicotinic receptors. Prog Neurobiol 1997; 53: 199-237.
21. Perry EK, Morris CM, Court JA, Cheng A, Fairbairn AF, McKeith IG et al. Alteration in nicotine binding sites in Parkinson's disease, Lewy Body dementia and Alzheimer's disease: possible index of early neuropathology. Neuroscience 1995; 64: 385-395.
22. Bertrand D, Cooper E, Valera S, Rungger D, Ballivet M. Electrophysiology of neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes following nuclear injection of genes or cDNA. Meth Neurosci 1991; 4: 174-193.
23. Miledi R, Parker I, Sumikawa K. Transplanting receptors from brains into oocytes. Fidia Research Foundation Neuroscience Award Lectures, 1987-1988. Raven: New York, 1989, Vol 3, pp 57-90.
24. Methfessel C, Witzemann V, Takahashi T, Mishina M, Numa S, Sakmann B. Patch clamp measurements in Xenopus laevis oocytes: currents through endogenous channels and implanted acetylcholine receptor and sodium channels. Pflügers Archiv Eur J Physiol 1986; 407: 577-588.
25. Miledi R, Parker I, Sumikawa K. Recording of single γ-aminobutyrate- and acetylcholine-activated receptor channels translated by exogenous mRNA in Xenopus oocytes. Proc Roy Soc B 1983; 218: 481-184.
26. Mileo AM, Palma E, Polenzani L, Limatola C, Grassi F, Eusebi F. Protein kinase C modulates exogenous acetylcholine current in Xenopus oocytes. J Neurosci Res 1995; 41: 443-451.